Sign Up Today and Learn More About Venture Med Group Stock
Invest in or calculate the value of your shares in Venture Med Group or other pre-IPO companies through EquityZen's platform.
Venture Med Group Stock
Venture Med Group develops medical devices for vascular health, focusing on peripheral artery disease and arteriovenous access treatment.
About Venture Med Group Stock
Founded
2012
Headquarters
Plymouth, MN, US
Industries
Software, Artificial Intelligence, Data and Analytics
Venture Med Group Press Mentions
Stay in the know about the latest news on Venture Med Group
FLEX Vessel Prep™ System Spotlighted for Clinical Outcomes, Staff Efficiency Gains, and Real-World Physician Experience in the Journal of Vascular Access, Vascular News, and Endovascular Today
prnewswire • Sep 12, 2025
Intravascular device for treating fistulas
patents • May 04, 2025
FLEX Vessel Prep™ System FLEX FIRST AV Registry 6-Month Data and the Hamburg Vessel Prep Experience Prior to Angioplasty presented at Charing Cross Symposium
prnewswire • Apr 23, 2025
VentureMed Strengthens Commercial Leadership and Expands Clinical Evidence to Drive FLEX Vessel Prep™ System Growth
morningstar • Mar 13, 2025
Intravascular catheter having an expandable incising portion and embolic …
patents • Feb 12, 2025
Venture Med Group Management
Leadership team at Venture Med Group
Founder, Chairman & Chief Science Officer
John Pigott
Vice President of Sales
Dave Michaelson
Join now and verify your accreditation status to gain access to:
- Venture Med Group Current Valuation
- Venture Med Group Stock Price
- Venture Med Group Management
- Available deals in Venture Med Group and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Venture Med Group Cap Table and Funding History by Share Class and Liquidity Preferences
- Venture Med Group Revenue and Financials
- Venture Med Group Highlights
- Venture Med Group Business Model
- Venture Med Group Risk Factors
- Venture Med Group Research Report from SACRA Research
Trading Venture Med Group Stock
How to invest in Venture Med Group stock?
Accredited investors can buy pre-IPO stock in companies like Venture Med Group through EquityZen funds. These investments are made available by existing Venture Med Group shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Venture Med Group stock?
Shareholders can sell their Venture Med Group stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."